Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangdong Cheng

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|November 14, 2017
[Conversion therapy of advanced gastric cancer]Xiangdong Cheng, Zonglei Mao
Future Oncology (London, England)|December 19, 2017
A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese populationXiangdong Cheng, Yi Lu
Archives of Medical Science : AMS|February 14, 2022
CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K/Akt signaling pathwayYubing Li, Xiangdong Cheng, Jiasheng Yan, et al.
Cell Biology and Toxicology|May 23, 2008
Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment cultureChong Shen, Xiangdong Cheng, Donghui Li, et al.
Journal of Evidence-Based Medicine|May 14, 2021
The role of miRNAs in MDMX-p53 interplayDehua Yu, Zhiyuan Xu, Xiangdong Cheng, et al.
Frontiers in Immunology|December 12, 2022
The usefulness of pretreatment controlling nutritional status score for predicting recurrence in patients with esophageal squamous cell carcinoma undergoing neoadjuvant immunochemotherapy: A real-world studyJifeng Feng, Liang Wang, Xun Yang, et al.
Frontiers in Nutrition|November 28, 2022
Prognostic prediction by a novel integrative inflammatory and nutritional score based on least absolute shrinkage and selection operator in esophageal squamous cell carcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
Biomolecules & Biomedicine|July 26, 2022
Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world studyJifeng Feng, Liang Wang, Xun Yang, et al.
Medical Hypotheses|August 6, 2013
TAK-242 can be the potential agents for preventing invasion and metastasis of hepatocellular carcinomaPengfei Yu, Xiangdong Cheng, Yian Du, et al.
Frontiers in Immunology|November 13, 2023
A novel immune-nutritional score predicts response to neoadjuvant immunochemotherapy after minimally invasive esophagectomy for esophageal squamous cell carcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|November 14, 2017
[Conversion therapy of advanced gastric cancer]Xiangdong Cheng, Zonglei Mao
Future Oncology (London, England)|December 19, 2017
A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese populationXiangdong Cheng, Yi Lu
Archives of Medical Science : AMS|February 14, 2022
CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K/Akt signaling pathwayYubing Li, Xiangdong Cheng, Jiasheng Yan, et al.
Cell Biology and Toxicology|May 23, 2008
Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment cultureChong Shen, Xiangdong Cheng, Donghui Li, et al.
Journal of Evidence-Based Medicine|May 14, 2021
The role of miRNAs in MDMX-p53 interplayDehua Yu, Zhiyuan Xu, Xiangdong Cheng, et al.
Frontiers in Immunology|December 12, 2022
The usefulness of pretreatment controlling nutritional status score for predicting recurrence in patients with esophageal squamous cell carcinoma undergoing neoadjuvant immunochemotherapy: A real-world studyJifeng Feng, Liang Wang, Xun Yang, et al.
Frontiers in Nutrition|November 28, 2022
Prognostic prediction by a novel integrative inflammatory and nutritional score based on least absolute shrinkage and selection operator in esophageal squamous cell carcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
Biomolecules & Biomedicine|July 26, 2022
Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world studyJifeng Feng, Liang Wang, Xun Yang, et al.
Medical Hypotheses|August 6, 2013
TAK-242 can be the potential agents for preventing invasion and metastasis of hepatocellular carcinomaPengfei Yu, Xiangdong Cheng, Yian Du, et al.
Frontiers in Immunology|November 13, 2023
A novel immune-nutritional score predicts response to neoadjuvant immunochemotherapy after minimally invasive esophagectomy for esophageal squamous cell carcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
Pageof 16